Featured Research

from universities, journals, and other organizations

For many older adults, vision prescription differs between eyes

Date:
November 26, 2013
Source:
Wolters Kluwer Health: Lippincott Williams & Wilkins
Summary:
Follow-up in older adults shows a high rate of anisometropia, or differing levels of visual abnormalities between eyes, reports a study.

Follow-up in older adults shows a high rate of anisometropia, or differing levels of visual abnormalities between eyes, reports a study in Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

"Uncorrected anisometropia is likely to lead to disturbances in binocular vision and stereopsis, which in turn may contribute to falls in the elderly," concludes the new research, led by Gunilla Haegerstrom-Portnoy, OD, PhD, FAAO, of University of California, Berkeley. They emphasize the importance of appropriate vision correction in both eyes for older adults -- especially at more advanced ages.

Study Confirms Increased Anisometropia with Aging

The researchers analyzed vision examination results in 118 older adults followed up over 12 years -- from an average age of 67 to 79 years at the end of the study. The study focused on the development of anisometropia, defined as a significant difference (one diopter or more) in prescription (refractive error) between the two eyes in one of four components.

During the study period, the prevalence of anisometropia increased significantly. For each of the four prescription components, the prevalence of anisometropia approximately doubled. As the participants approached 80 years of age, 32 percent met the study definition of anisometropia.

The differences in prescription components provided some clues to the causes of aging-related anisometropia. Most cases were related to differing degrees of farsightedness (hyperopia) between eyes. Others were caused by early but unequal blurring of the lens of the eye -- even though none of the older adults in the study had eye lenses that met the usual clinical definition of cataracts.

Within the age range studied, differences between eyes could begin to occur anytime, with no particular preference for any one age. In a few patients, anisometropia actually decreased during the study.

Need for Proper Correction in Both Eyes

Previous studies, based on cross-sectional (one-time) measurements, have suggested that the rate of anisometropia increases exponentially with aging. However, these studies provide no information on how the visual mismatch develops over time, or the specific refractive error components involved.

Dr Haegerstrom-Portnoy and coauthors cite previous studies showing that the prevalence of anisometropia in children is only two to four percent. They write, "Whatever the cause of the increase in anisometropia with aging, the fact that significant anisometropia is at least ten times more common in those over 75 years of age than in children needs to be clearly emphasized to clinicians."

Anthony Adams, OD, PhD, Editor-in-Chief of Optometry and Vision Science, comments: "For older people a lack of correction of this prescription difference between the eyes may contribute to the increased frequency of falls that, in turn, can have a severe impact on health and even life expectancy." Under current American Academy of Optometry guidelines, people over age 65 are considered a high-risk group, for whom visual examination and screening are recommended at least every two years.

Dr Adams raises special concern over the frequent use of "over-the-counter drugstore reading glasses" by older adults. He adds, "These 'dime store readers' are made to be generic, with identical focusing or magnification power in each eye -- certainly not an ideal solution for at least 30 percent of the over-age-75 population who have differing visual requirements between eyes."


Story Source:

The above story is based on materials provided by Wolters Kluwer Health: Lippincott Williams & Wilkins. Note: Materials may be edited for content and length.


Journal Reference:

  1. Gunilla Haegerstrom-Portnoy, Marilyn E. Schneck, Lori A. Lott, Susan E. Hewlett, John A. Brabyn. Longitudinal Increase in Anisometropia in Older Adults. Optometry and Vision Science, 2013; 1 DOI: 10.1097/OPX.0000000000000114

Cite This Page:

Wolters Kluwer Health: Lippincott Williams & Wilkins. "For many older adults, vision prescription differs between eyes." ScienceDaily. ScienceDaily, 26 November 2013. <www.sciencedaily.com/releases/2013/11/131126155834.htm>.
Wolters Kluwer Health: Lippincott Williams & Wilkins. (2013, November 26). For many older adults, vision prescription differs between eyes. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/11/131126155834.htm
Wolters Kluwer Health: Lippincott Williams & Wilkins. "For many older adults, vision prescription differs between eyes." ScienceDaily. www.sciencedaily.com/releases/2013/11/131126155834.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins